EUVIMEDEUVIMED entdecken
Crossref

Sample Size Assessment and Interim Analysis Strategies for Survival Trial Designs With Covariate‐Adaptive Randomization

Pei-Fang Su iD, Chieh-Chi Wu

Statistics in Medicine · 2025

DOI: 10.1002/sim.70149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Statistics in Medicine, 2025. Verfasst von Pei-Fang Su und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Statistics, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Research Design. Die Arbeit nennt 28 Literaturangaben. Gefördert von: National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Estimating the required sample size is an essential task for a clinical trial. It ensures statistical power and makes it possible to draw meaningful conclusions from the study results. Moreover, to minimize treatment imbalances within each covariate subgroup, covariate‐adaptive randomization is a popular method. The first aim of this study is to investigate the required sample size for covariate‐adaptive randomization based on survival outcomes. We evaluate the testing performance using the calculated sample size under simple randomization, stratified permuted block randomization, and covariate‐adaptive biased coin randomization. To provide preliminary insights into the trial's progress and potential efficacy, an interim analysis is commonly conducted. The second aim of the study is to provide a strategy for interim analysis in covariate‐adaptive randomization trials, which involves stopping the trial early based on accumulating data if one treatment arm proves to be significantly more effective or harmful than the others. Because the data collected before and after the interim monitoring time are dependent, performing multiple tests may inflate the overall Type I error rate. We thus re‐estimate the required sample size, propose a valid hypothesis testing method for interim analysis, and study the underlying theoretical properties of the testing statistics, incorporating covariate‐adaptive randomization. The performance of the proposed formula and interim strategy is evaluated through comprehensive simulations, including a sensitivity analysis. We also provide the R code to benefit the readers. Finally, two survival trials, the RE01 trial and a lung cancer study, are treated as pilot studies, and we show that the proposed strategies are valid under covariate‐adaptive randomization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicResearch DesignHumansSample SizeSurvival AnalysisComputer SimulationLung NeoplasmsModels, StatisticalData Interpretation, StatisticalRandom Allocation

Stichwörter der Autor:innen

biased coin randomizationcox modelpowersensitivity analysisstratified permuted block randomizationtype I error rate

Autor:innen und Institutionen

  • Department of Statistics, National Cheng Kung University, Tainan, Taiwan.

ORCID-Profile: Pei-Fang Su

Förderung

  • National Science and Technology Council

Zitieren

APA

Su, P. F., & Wu, C. C. (2025). Sample Size Assessment and Interim Analysis Strategies for Survival Trial Designs With Covariate‐Adaptive Randomization. Statistics in Medicine. https://doi.org/10.1002/sim.70149

Vancouver

Su PF, Wu CC. Sample Size Assessment and Interim Analysis Strategies for Survival Trial Designs With Covariate‐Adaptive Randomization. Statistics in Medicine. 2025. doi:10.1002/sim.70149

BibTeX
@article{Su2025,
  author = {Su, Pei-Fang and Wu, Chieh-Chi},
  title = {Sample Size Assessment and Interim Analysis Strategies for Survival Trial Designs With Covariate‐Adaptive Randomization},
  journal = {Statistics in Medicine},
  year = {2025},
  doi = {10.1002/sim.70149}
}
Kostenlos starten →